Regulation of intracellular glucocorticoid concentrations
US7122532B2 · kind B2 · utility
38Cited by
2References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 22, 2002 |
| Grant date | Oct 17, 2006 |
| Priority date | — |
| Expiry date | Sep 19, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/24
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the interconversion of inactive 11-keto steroids with their active 11B-hydroxy equivalents, to methods by which the conversion of the inactive to the active form may be controlled, and to useful therapeutic effects which may be obtained as a result of such control. More specifically, but not exclusively, the invention is concerned with interconversion between cortisone and cortisol in humans.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.